Anti-vascular endothelial growth factor therapy for age-related macular degeneration: a systematic review and network meta-analysis

BACKGROUND: The comparative safety and efficacy between anti-vascular endothelial growth factor agents (anti-VEGFs) and between combined therapies for patients with neovascular age-related macular degeneration (nAMD) is unclear. We conducted a systematic review to examine the comparative safety and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tricco, Andrea C., Thomas, Sonia M., Lillie, Erin, Veroniki, Areti Angeliki, Hamid, Jemila S., Pham, Ba’, Lee, Taehoon, Agarwal, Arnav, Sharpe, Jane P., Scott, Alistair, Warren, Rachel, Brahmbhatt, Ronak, Macdonald, Erin, Janoudi, Ghayath, Muni, Rajeev H., Francisconi, Carolina L. M., Richter, Trevor, Straus, Sharon E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690960/
https://www.ncbi.nlm.nih.gov/pubmed/34930439
http://dx.doi.org/10.1186/s13643-021-01864-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690960/
https://www.ncbi.nlm.nih.gov/pubmed/34930439
http://dx.doi.org/10.1186/s13643-021-01864-6

Ejemplares similares